JP2024536609A5 - - Google Patents

Info

Publication number
JP2024536609A5
JP2024536609A5 JP2024524678A JP2024524678A JP2024536609A5 JP 2024536609 A5 JP2024536609 A5 JP 2024536609A5 JP 2024524678 A JP2024524678 A JP 2024524678A JP 2024524678 A JP2024524678 A JP 2024524678A JP 2024536609 A5 JP2024536609 A5 JP 2024536609A5
Authority
JP
Japan
Prior art keywords
methyl
oral formulation
coated
hpmcas
formulation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024524678A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536609A (ja
Filing date
Publication date
Priority claimed from PCT/EP2021/079584 external-priority patent/WO2023072368A1/en
Application filed filed Critical
Publication of JP2024536609A publication Critical patent/JP2024536609A/ja
Publication of JP2024536609A5 publication Critical patent/JP2024536609A5/ja
Pending legal-status Critical Current

Links

JP2024524678A 2021-10-25 2022-10-24 ピリジノン誘導体の経口製剤および腸線維症の予防および/または治療におけるその使用 Pending JP2024536609A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2021/079584 WO2023072368A1 (en) 2021-10-25 2021-10-25 Oral formulation of a pyridinone derivate and use thereof in prophylaxis and/or treatment of intestinal fibrosis
EPPCT/EP2021/079584 2021-10-25
PCT/EP2022/079666 WO2023072878A1 (en) 2021-10-25 2022-10-24 Oral formulation of a pyridinone derivate and use thereof in prophylaxis and/or treatment of intestinal fibrosis

Publications (2)

Publication Number Publication Date
JP2024536609A JP2024536609A (ja) 2024-10-04
JP2024536609A5 true JP2024536609A5 (cg-RX-API-DMAC7.html) 2025-11-05

Family

ID=78536154

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024524678A Pending JP2024536609A (ja) 2021-10-25 2022-10-24 ピリジノン誘導体の経口製剤および腸線維症の予防および/または治療におけるその使用

Country Status (11)

Country Link
US (1) US20250041228A1 (cg-RX-API-DMAC7.html)
EP (1) EP4312994A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024536609A (cg-RX-API-DMAC7.html)
KR (1) KR20240093898A (cg-RX-API-DMAC7.html)
CN (1) CN118234489A (cg-RX-API-DMAC7.html)
AU (1) AU2022374695A1 (cg-RX-API-DMAC7.html)
CA (1) CA3230682A1 (cg-RX-API-DMAC7.html)
IL (1) IL312176A (cg-RX-API-DMAC7.html)
MX (1) MX2024005076A (cg-RX-API-DMAC7.html)
WO (2) WO2023072368A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202402786B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL297020A (en) 2020-04-24 2022-12-01 Dr Falk Pharma Gmbh A systemic preparation of a pyridonone derivative related to tg2
HRP20231072T1 (hr) 2020-04-24 2023-12-22 Dr. Falk Pharma Gmbh Sustavna formulacija derivata piridinona za celijakiju
WO2025153465A1 (en) * 2024-01-15 2025-07-24 UCB Biopharma SRL Method for the treatment of fibrotic-related disorder associated to ibd

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006052755A1 (de) * 2006-11-08 2008-05-15 N-Zyme Biotec Gmbh Michaelsysteme als Transglutaminaseinhibitoren
EP2687511A1 (de) * 2012-07-17 2014-01-22 Zedira GmbH Pyridinonderivate als Gewebetransglutaminaseinhibitoren

Similar Documents

Publication Publication Date Title
JP5705319B2 (ja) 1種以上のアルギン酸の塩を含む胃液抵抗性の医薬又は栄養補助製剤
JP2011513204A5 (cg-RX-API-DMAC7.html)
JP2002527468A (ja) 脈動用量薬剤経口送達システム
KR102381586B1 (ko) 메살라진의 경구용 약제학적 조성물
AU3492201A (en) Timed pulsatile drug delivery systems
JP2009538315A (ja) 塩酸デュロキセチン遅延放出型製剤
NZ547284A (en) Pharmaceutical agent-containing formulation comprising a coating of a film forming polymer
US20100247645A1 (en) Pharmaceutical combination of aliskiren and valsartan
CN101010070A (zh) 药物组合物
JP2024506595A5 (cg-RX-API-DMAC7.html)
CN101861138A (zh) 控释的阿奇霉素固体剂型
JPH0826977A (ja) 溶出制御型経口製剤
JP2024536609A (ja) ピリジノン誘導体の経口製剤および腸線維症の予防および/または治療におけるその使用
AU2018286535B2 (en) Delayed sustained release pharmaceutical compositions
JP7021108B2 (ja) ニコチンアミドの経口薬学的組成物
JP2007530492A5 (cg-RX-API-DMAC7.html)
CN100361660C (zh) 左氧氟沙星缓释微丸、其制备方法及其制药用途
JP7423629B2 (ja) 結腸ドラッグデリバリー製剤
WO2005051362A2 (en) Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating
US10946002B2 (en) Pharmaceutical suspension dosage form of benzimidazole compounds and process of preparation thereof
TW201813643A (zh) 杜洛希酊腸衣包覆醫藥組成物及其製造方法
TWI408130B (zh) 度若西汀腸衣組合物
KR20070042073A (ko) 새로운 서방성 다중 유닛 제형
HK40005191B (en) Oral pharmaceutical compositions of nicotinamide
HK40005191A (en) Oral pharmaceutical compositions of nicotinamide